| Literature DB >> 35163870 |
Mustapha Muhammad Nasiru1,2,3, Muhammad Umair4, Evans Frimpong Boateng1, Fawze Alnadari2, Kashif-Ur Rehman Khan5, Zhaobin Wang1,2, Ji Luo6, Wenjing Yan1,2, Hong Zhuang7, Ali Majrashi8, Jianhao Zhang1,2, Sameh A Korma9,10.
Abstract
Egg white protein (EWP) is susceptible to denaturation and coagulation when exposed to high temperatures, adversely affecting its flavour, thereby influencing consumers' decisions. Here, we employ high-voltage cold plasma (HVCP) as a novel nonthermal technique to investigate its influence on the EWP's flavour attributes using E-nose, E-tongue, and headspace gas-chromatography-ion-mobilisation spectrometry (HS-GC-IMS) due to their rapidness and high sensitivity in identifying flavour fingerprints in foods. The EWP was investigated at 0, 60, 120, 180, 240, and 300 s of HVCP treatment time. The results revealed that HVCP significantly influences the odour and taste attributes of the EWP across all treatments, with a more significant influence at 60 and 120 s of HVCP treatment. Principal component analyses of the E-nose and E-tongue clearly distinguish the odour and taste sensors' responses. The HS-GC-IMS analysis identified 65 volatile compounds across the treatments. The volatile compounds' concentrations increased as the HVCP treatment time was increased from 0 to 300 s. The significant compounds contributing to EWP characterisation include heptanal, ethylbenzene, ethanol, acetic acid, nonanal, heptacosane, 5-octadecanal, decanal, p-xylene, and octanal. Thus, this study shows that HVCP could be utilised to modify and improve the EWP flavour attributes.Entities:
Keywords: E-nose; E-tongue; PCA; PLS-DA; egg white protein; flavour; high-voltage cold plasma; volatile compounds
Mesh:
Substances:
Year: 2022 PMID: 35163870 PMCID: PMC8838924 DOI: 10.3390/molecules27030601
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Chemical components composition of HVCP treated EWP.
| Chemical Component Composition (% | Treatment Time (s) | |||||
|---|---|---|---|---|---|---|
| 0 | 60 | 120 | 180 | 240 | 300 | |
|
| 88.33 ± 0.58 a | 88.33 ± 0.58 a | 88.37 ± 1.00 a | 87.77 ± 0.55 a | 87.43 ± 0.78 a | 88.33 ± 0.79 a |
|
| 11.00 ± 0.00 a | 10.83 ± 0.21 a | 10.83 ± 0.21 a | 10.79 ± 0.17 a | 10.92 ± 0.07 a | 11.00 ± 0.07 a |
|
| 0.79 ± 0.01 a | 0.79 ± 0.01 a | 0.75 ± 0.06 a | 0.80 ± 0.13 a | 0.95 ± 0.03 b | 0.95 ± 0.03 b |
|
| 0.19 ± 0.01 a | 0.18 ± 0.02 a | 0.18 ± 0.02 a | 0.18 ± 0.02 a | 0.19 ± 0.01 a | 0.19 ± 0.01 a |
Data = mean ± SD. SD: Standard deviation. Different superscript letters (a, b) mean values are significantly different (p ≤ 0.05) across the treatment time. %w/w: percentage weight per weight.
Figure 1(a) PCA plot describing the variation in the odour fingerprints of HVCP treated EWP; (b) Loading plot describing the distribution of odour fingerprints across various HVCP treatments on the EWP; CK: Control; PC1: Principal component 1; PC2: Principal component 2; W1C: Aromatic compounds; W5S: Ammonia and aromatic molecules; W3C: Broad-nitrogen oxide; W6S: Hydrogen; W5C: Methane, propane and aliphatics; W1S: Broad-methane; W1W: Sulphur-containing organics; W2S: Broad-alcohols, broad-carbon chains; W2W: Aromatic, sulphur-and chlorine-containing organics and W3S: Methane and aliphatics.
Figure 2(a) PCA plot describing the variation in the taste fingerprints of HVCP-treated EWP; (b) Loading plot describing the distribution of taste fingerprints across various HVCP treatment on the EWP.CK: Control; PC1: Principal component 1; PC2: Principal component 2; AAE: Umami; CTO: Saltiness; CAO: Sourness; COO: Bitterness and AEI: Astringency.
Figure 3(a) Radar plot describing the influence of HVCP treatment on the odour fingerprints of the EWP; (b) Radar plot describing the influence of HVCP treatment on the taste fingerprints of the EWP.W1C: Aromatic compounds; W5S: Ammonia and aromatic molecules; W3C: Broad-nitrogen oxide; W6S: Hydrogen; W5C: Methane, propane and aliphatics; W1S: Broad-methane; W1W: Sulphur-containing organics; W2S: Broad-alcohols, broad-carbon chains; W2W: Aromatic, sulphur-and chlorine-containing organics and W3S: Methane and aliphatics. AAE: Umami; CTO: Saltiness; CAO: Sourness; COO: Bitterness and AEI: Astringency.
Figure 4Heatmap showing individual concentration of volatile compounds identified in the HVCP-treated EWP at different treatment times.
Volatile compounds identified in the egg white protein-treated high-voltage cold plasma using HS-GC-IMS.
| Classification | RT | Volatile Compounds Attributes | Area (%) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name | SI | RSI | CAS No. | Formula | Control | 60 s | 120 s | 180 s | 240 s | 300 s | ||
| Acids | 43.03 | Alpha-Muricholic acid | 607 | 629 | 2393-58-0 | C24H40O5 | - | - | - | - | - | 1.48 ± 0.11 vA |
|
|
| |||||||||||
| Alcohols | 3.08 | Ethanol | 860 | 867 | 64-17-5 | C2H6O | 0.39 ± 0.04 aA | 0.41 ± 0.06 aA | 0.50 ± 0.09 aB | 0.58 ± 0.12 aB | 0.45 ± 0.36 aB | 0.65 ± 0.15 aC |
| 4.82 | 1-Deoxy-d-mannitol | 639 | 676 | 60965-81-3 | C14H14O5 | - | - | - | 0.02 ± 0.01 bA | - | - | |
| 21.42 | 1,4-Benzenediol, 2,6-bis(1,1-dimethylethyl)- | 608 | 629 | 2444-28-2 | C14H22O2 | - | - | - | - | 0.19 ± 0.03 cA | 0.19 ± 0.02 iB | |
| 33.31 | Ethanol, 2-(octadecyloxy)- | 727 | 755 | 2136-72-3 | C20H42O2 | - | 0.22 ± 0.03 mA | 0.23 ± 0.08 iA | 0.26 ± 0.08 oB | 0.30 ± 0.27 aB | 0.37 ± 0.02 oB | |
| 34.46 | 1-Hexadecanol, 2-methyl- | 694 | 720 | 2490-48-4 | C17H36O | - | 0.18 ± 0.03 hA | - | - | 0.66 ± 0.31 wB | - | |
| 34.64 | 1-Dodecanol, 3,7,11-trimethyl- | 725 | 755 | 6750-34-1 | C15H32O | - | 0.18 ± 0.10 hA | 0.25 ± 0.11 dA | 0.66 ± 0.31 pB | - | - | |
| 36.94 | Phenol, 2,6-bis(1,1-dimethylethyl)- | 875 | 927 | 128-39-2 | C14H22O | - | 11.01 ± 1.11 oA | - | - | - | - | |
| 36.94 | 2,4-Di-tert-butylphenol | 889 | 889 | 96-76-4 | C14H22O | - | - | 8.98 ± 0.64 oA | - | 7.82 ± 0.58 lA | 6.86 ± 0.82 qA | |
| 39.15 | Phenol, 2,6-bis(1,1-dimethylethyl)-4-(1-methylpropyl)- | 815 | 857 | 17540-75-9 | C18H30O | 0.59 ± 0.10 hA | 0.52 ± 0.02 pB | 0.53 ± 0.06 pC | 0.63 ± 0.03 yD | 0.54 ± 0.06 mE | 0.61 ± 0.02 tF | |
|
|
|
|
|
|
|
| ||||||
| Aldehydes | 4.81 | DL-Arabinose | 628 | 662 | 20235-19-2 | C5H10O5 | - | - | 0.01 ± 0.01 bA | 0.02 ± 0.01 bA | - | 0.01 ± 0.01 bA |
| 12.63 | Hexanal | 709 | 893 | 66-25-1 | C6H12O | - | - | - | 0.19 ± 0.02 dA | - | - | |
| 17.59 | Heptanal | 717 | 810 | 111-71-7 | C7H14O | 0.09 ± 0.01 aA | 0.14 ± 0.03 dB | 0.16 ± 0.02 iC | 0.18 ± 0.02 dB | 0.23 ± 0.03 cE | 0.20 ± 0.02 fE | |
| 21.12 | Cyclohexanone, 2-ethyl- | 756 | 779 | 4423-94-3 | C8H14O | 5.07 ± 1.31 eA | - | 6.6 ± 0.30 kA | 5.39 ± 0.65 jA | 5.84 ± 0.21 gA | - | |
| 21.77 | Octanal | 748 | 889 | 124-13-0 | C8H16O | 0.10 ± 0.1 aA | 0.14 ± 0.02 dB | 0.14 ± 0.03 iC | 0.15 ± 0.02 eB | 0.21 ± 0.02 cD | 0.19 ± 0.01 iD | |
| 25.43 | Nonanal | 818 | 876 | 124-19-6 | C9H18O | 2.90 ± 0.38 fA | 3.68 ± 0.34 ìA | 4.03 ± 0.36 mA | 3.83 ± 0.30 kB | 4.77 ± 0.11 hC | 4.52 ± 0.35 lD | |
| 20.28 | Benzaldehyde | 636 | 873 | 100-52-7 | C7H6O | - | - | 0.59 ± 0.03 jA | 0.61 ± 0.03 iB | 0.44 ± 0.12 aB | 0.55 ± 0.05 hB | |
| 27.26 | Retinal | 603 | 704 | 116-31-4 | C20H28O | - | 0.13 ± 0.03 dA | - | - | - | - | |
| 28.74 | Decanal | 838 | 873 | 112-31-4 | C20H28O | 0.54 ± 0.05 aA | 0.72 ± 0.05 jA | 0.7 ± 0.17 nA | 0.87 ± 0.05 mB | 1.09 ± 0.05 iC | 1.15 ± 0.15 nD | |
| 34.09 | 4-Octadecenal | 716 | 747 | 56554-98-4 | C18H34O | - | 0.11 ± 0.04 gA | - | - | - | - | |
| 38.32 | 5-Octadecenal | 724 | 757 | 56554-88-2 | C18H34O | 0.30 ± 0.10 aA | 0.20 ± 0.13 hB | 0.49 ± 0.13 aC | 0.82 ± 0.08 vD | 0.33 ± 0.06 aA | 0.46 ± 0.03 rC | |
|
|
|
|
|
|
|
| ||||||
| Alkanes | 28.82 | Octadecane, 6-methyl- | 705 | 785 | 10544-96-4 | C19H40 | 0.23 ± 0.14 aA | - | - | - | - | - |
| 33.45 | Hexadecane, 1,1-bis(dodecyloxy)- | 727 | 733 | 56554-64-4 | C40H82O2 | - | 0.20 ± 0.04 hA | - | - | 0.14 ± 0.05 cB | - | |
| 36.75 | Tetradecane, 2,6,10-trimethyl- | 739 | 815 | 14905-56-7 | C17H36 | 0.42 ± 0.15 aA | - | 0.36 ± 0.24 eB | 0.46 ± 0.27 sA | - | 0.55 ± 0.27 hA | |
| 41.04 | (Z,Z)-9-Octadecene, 1,1’-[1,2-ethanediylbis(oxy)]bis- | 678 | 695 | 17367-13-4 | C38H74O2 | 0.22 ± 0.12 aA | - | 0.18 ± 0.02 iA | - | 0.16 ± 0.02 cA | - | |
| 41.59 | Octadecane, 3-ethyl-5-(2-ethylbutyl)- | 715 | 721 | 55282-12-7 | C26H54 | 0.41 ± 0.23 aA | - | - | 0.51 ± 0.02 aB | - | 0.72 ± 0.21 uC | |
|
|
|
|
|
|
|
| ||||||
| Cucurbitacins | 36.28 | Cucurbitacin B, dihydro- | 600 | 661 | 13201-14-4 | C32H48O8 | - | 0.18 ± 0.03 hA | 0.13 ± 0.07 iA | 0.20 ± 0.04 dA | 0.22 ± 0.03 cA | 0.18 ± 0.10 jA |
|
|
|
|
|
|
| |||||||
| Esters | 9.05 | Acetic acid, hydroxy-, ethyl ester | 867 | 970 | 623-50-7 | C4H8O3 | 1.18 ± 0.14 bA | 1.25 ± 0.09 bA | 1.47 ± 0.16 cA | 1.79 ± 0.14 cB | 1.89 ± 0.25 bB | 1.91 ± 0.34 cB |
| 24.60 | 10,13-Octadecadiynoic acid, methyl ester | 615 | 621 | 18202-24-9 | C19H30O2 | - | - | - | - | - | 0.01 ± 0.00 bA | |
| 25.80 | (Z)-Stearic acid, 2-(9-octadecenyloxy)ethyl ester | 627 | 648 | 29027-97-2 | C38H74O3 | - | - | 0.04 ± 0.01 fA | - | - | - | |
| 29.09 | 1,3-Dioxane, 4-(hexadecyloxy)-2-pentadecyl- | 603 | 725 | 34315-34-9 | C35H70O3 | - | - | - | 0.22 ± 0.06 dA | 0.23 ± 0.06 cA | - | |
| 31.03 | Stearic acid, 3-(octadecyloxy)propyl ester | 553 | 642 | 17367-40-7 | C39H78O3 | 0.33 ± 0.22 aA | 0.39 ± 0.20 lA | - | 0.42 ± 0.08 nA | 0.27 ± 0.11 dB | 0.5 ± 0.03 mC | |
| 31.15 | Octadecanoic acid, 2-(octadecyloxy)ethyl ester | 644 | 658 | 28843-25-6 | C38H76O3 | - | - | - | - | - | 0.26 ± 0.02 eA | |
| 33.19 | 1,2-Propanediol, 3-(octadecyloxy)-, diacetate | 631 | 679 | 21994-81-0 | C25H48O5 | - | - | 0.16 ± 0.06 iA | 0.20 ± 0.03 dB | - | - | |
| 33.57 | Octadecane, 1,1’-[(1-methyl-1,2-ethanediyl)bis(oxy)]bis- | 562 | 673 | 35545-51-8 | C39H80O2 | - | 0.56 ± 0.04 kA | - | - | 0.47 ± 0.12 aA | - | |
| 36.09 | Geranyl isovalerate | 625 | 660 | 109-20-6 | C15H26O2 | 0.09 ± 0.03 aA | - | - | - | - | - | |
| 37.31 | Oleic acid, 3-(octadecyloxy)propyl ester | 678 | 709 | 17367-41-8 | C39H76O3 | - | 0.13 ± 0.13 dA | 0.13 ± 0.09 iB | 0.33 ± 0.04 uC | 0.29 ± 0.04 aC | - | |
| 39.55 | Docosanoic acid, 8,9-dihydroxy-, methyl ester | 616 | 635 | 56555-06-7 | C23H46O4 | - | 0.43 ± 0.04 qA | - | 0.52 ± 0.03 zB | 0.53 ± 0.03 mB | 0.55 ± 0.03 hC | |
| 39.99 | Octadecanoic acid, 4-hydroxy-, methyl ester | 627 | 681 | 2420-38-4 | C19H76O4 | - | 0.22 ± 0.15 hA | - | 0.27 ± 0.13 tB | - | - | |
| 41.05 | (Z,Z)-9-Hexadecenoic acid, 9-octadecenyl ester | 672 | 691 | 22393-98-2 | C34H64O2 | - | - | - | 0.22 ± 0.04 cA | - | - | |
| 41.50 | Oleic acid, eicosyl ester | 655 | 670 | 22393-88-0 | C38H74O2 | - | - | - | - | 0.14 ± 0.02 cA | 0.20 ± 0.04 fB | |
| 43.02 | 1,3-Dioxane, 5-(hexadecyloxy)-2-pentadecyl-, trans- | 603 | 725 | 56599-40-7 | C35H70O3 | - | - | - | 1.5 ± 0.04 cA | - | - | |
| 43.22 | 1,2-Benzenedicarboxylic acid, butyl octyl ester | 741 | 803 | 84-78-6 | C20H30O4 | - | 0.49 ± 0.21 rA | - | - | - | 0.5 ± 0.16 mB | |
|
|
|
|
|
|
|
| ||||||
| Hydrocarbons | 16.05 | Ethylbenzene | 737 | 887 | 100-41-4 | C8H10 | 0.16 ± 0.12 aA | 0.24 ± 0.01 cA | 0.24 ± 0.13 dA | 0.14 ± 0.09 eA | 0.17 ± 0.11 cA | 0.09 ± 0.00 dA |
| 16.08 | Benzene, 1,3-dimethyl- | 843 | 873 | 108-38-3 | C8H10 | - | 0.14 ± 0.10 dA | 0.25 ± 0.16 dB | 0.15 ± 0.11 eA | 0.28 ± 0.17 dB | 0.21 ± 0.10 fB | |
| 16.29 | p-Xylene | 831 | 888 | 106-42-3 | C8H10 | 0.37 ± 0.21 aA | 0.24 ± 0.01 cA | 0.34 ± 0.07 eA | 0.29 ± 0.05 fA | 0.34 ± 0.08 aA | 0.26 ± 0.02 eA | |
| 18.69 | Benzene, (1-methylethyl)- | 661 | 772 | 98-82-8 | C9H12 | - | - | - | - | - | 0.04 ± 0.01 aD | |
| 21.68 | Dodecane, 1,2-dibromo- | 606 | 675 | 55334-42-4 | C12H24Br2 | - | - | - | 0.14 ± 0.01 eA | - | - | |
| 21.96 | Decane | 622 | 871 | 124-18-5 | C10H22 | 0.1 ± 0.04 aA | - | - | - | - | - | |
| 23.12 | Cyclohexane, butyl- | 740 | 812 | 4292-92-6 | C11H22 | - | 0.10 ± 0.01 gA | - | - | - | - | |
| 23.93 | Heptylcyclohexane | 694 | 781 | 5617-41-4 | C13H26 | - | 0.12 ± 0.02 dA | - | - | 0.12 ± 0.03 cA | 0.16 ± 0.02 jB | |
| 24.77 | Dodecane, 2,6,11-trimethyl- | 717 | 864 | 31295-56-4 | C15H32 | - | - | - | - | - | 0.31 ± 0.09 bA | |
| 24.95 | Dodecane, 2,6,10-trimethyl- | 773 | 859 | 3891-98-3 | C15H32 | - | 0.18 ± 0.07 hA | - | 0.34 ± 0.19 lB | - | - | |
| 25.29 | Undecane | 713 | 869 | 1120-21-4 | C11H24 | - | - | 0.29 ± 0.01 lA | 0.30 ± 0.02 fB | 0.32 ± 0.02 aB | - | |
| 26.73 | Cyclohexane, pentyl- | 680 | 821 | 4292-92-6 | C11H22 | - | 0.12 ± 0.02 dA | - | - | - | - | |
| 28.55 | Dodecane | 725 | 799 | 112-40-3 | C12H44 | - | - | - | - | - | 0.50 ± 0.03 mA | |
| 31.60 | Heptadecane, 2,6,10,15-tetramethyl- | 717 | 815 | 54833-48-6 | C21H44 | - | - | - | - | - | 0.28 ± 0.03 eA | |
| 34.36 | Tetradecane | 802 | 904 | 629-59-4 | C10H30 | 0.66 ± 0.26 gA | - | 0.64 ± 0.22 nB | 1.00 ± 0.12 rC | 0.71 ± 0.19 jB | 1.04 ± 0.01 pD | |
| 35.79 | Nonadecane | 804 | 904 | 629-92-5 | C19H40 | 0.66 ± 0.25 gA | 0.59 ± 0.02 kA | 0.71 ± 0.16 nA | 0.96 ± 0.08 xB | - | - | |
| 38.36 | Heptacosane | 783 | 823 | 593-49-7 | C27H56 | 0.54 ± 0.15 aA | 0.55 ± 0.03 kA | 0.67 ± 0.09 nA | 0.73 ± 0.22 qB | 0.66 ± 0.05 kA | 0.84 ± 0.15 sC | |
| 38.64 | Hexadecane | 799 | 874 | 544-76-3 | C16H34 | - | - | - | 0.95 ± 0.07 xA | - | - | |
| 41.49 | Benzene, 1,1’-(1,2-cyclobutanediyl)bis-, trans- | 678 | 868 | 20071-09-4 | C16H16 | - | - | - | - | - | 0.71 ± 0.09 aA | |
| 41.72 | 17-Pentatriacontene | 658 | 672 | 6971-40-0 | C35H70 | - | - | 0.32 ± 0.04 qA | 0.41 ± 0.01 nB | 0.33 ± 0.03 aA | 0.45 ± 0.01 wC | |
|
|
|
|
|
|
|
| ||||||
| Ketones | 17.01 | 2-Heptanone | 660 | 744 | 110-43-0 | C7H14O | 0.05 ± 0.01 cA | 0.06 ± 0.01 eB | 0.07 ± 0.00 gC | 0.07 ± 0.01 gD | - | 0.09 ± 0.01 dE |
| 16.88 | 3-Heptanone | 652 | 730 | 106-35-4 | C7H14O | - | 0.06 ± 0.01 eA | - | - | 0.08 ± 0.02 | - | |
|
|
|
|
|
|
|
| ||||||
RT: Retention time; SI: Match factor; RSI: Reverse match factor. Lower case letters (a–z) means values are significantly different (p ≤ 0.05) across the treatment time. Upper case letters (A–F) means values are significantly different (p ≤ 0.05) across the volatile compounds’ area (area unit × 106). Values are mean ± standard deviation, n = 3.
Figure 5(a) The number of volatile compounds identified in the HVCP-treated EWP using HS-GC-IMS. (b) The concentrations of volatile compounds classes identified in the HVCP treated EWP using HS-GC-IMS.
Figure 6(a) PCA plot describing the variation in the volatile compounds’ fingerprints of HVCP-treated EWP; (b) Loading plot describing the distribution of volatile compounds’ fingerprints across various HVCP treatment on the EWP. PCA: Principal component analysis.
Figure 7(a) The variable importance for the projection (VIP) predictive PLS-DA model of the volatile organic compounds (VOCs); (b) PLS-DA score plot showing the variation in the volatile compounds’ fingerprints of HVCP treated EWP; (c) PLS-DA loading plot showing the distribution of volatile compounds fingerprints across various HVCP treatment on the EWP. PLS-DA: Partial Least-Square Discriminant Analysis; X: represents the variable; Y: represents the PLS-DA models for the six classes.